Sac-TMT Sequential Capecitabine Versus Capecitabine in Early-Stage High-Risk Triple-Negative Breast Cancer Without BRCA Mutations

Clinical trial NCT07628504 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07628504
Sponsor: Fudan University
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Adjuvant Drug Therapy

Start date: 2026-05-18
Primary completion: 2030-03-30
Enrollment: 420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.